Population
Postmenopausal women
Design
Editorial
Key result
Menopausal hormone therapy may mitigate the increase in central adiposity and associated cardiovascular risk that occurs during the postmenopausal years.
Authors
Loading...
Adipose tissue functions as a key estrogen reservoir post-menopause; leaves open cardiometabolic implications in Level 5 data.
Menopausal hormone therapy may mitigate the shift towards visceral adiposity and associated cardiovascular risk seen in postmenopausal women.
Spritzer et al. (2024) conducted a review in Postmenopausal adiposity and cardiovascular risk. Menopausal hormone therapy was evaluated. Menopausal hormone therapy may mitigate the increase in central adiposity and associated cardiovascular risk that occurs during the postmenopausal years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: